SCHEMBL10009836

SCHEMBL10009836

CC1(C)c2ccccc2-c2c1cc(-c1c3ccccc3c(-c3ccc4ccc5cccnc5c4n3)c3ccccc13)c1ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.37
CCR8 P51685 5/20 0.37
MAPT P10636 4/20 0.37
CCR5 P51681 3/20 0.37
LMNA P02545 3/20 0.37
KDM4E B2RXH2 3/20 0.37
TDP1 Q9NUW8 2/20 0.37
GMNN O75496 1/20 0.37
TP53 P04637 1/20 0.37
HSP90AA1 P07900 1/20 0.37
MMP2 P08253 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MMP9 P14780 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MMP8 P22894 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13024901 0.92 CCR1 (0.34) CCR1CCR8MAPTCCR5LMNA
SCHEMBL13150092 0.87 CCR1 (0.32) CCR1CCR8MAPTCCR5LMNA
SCHEMBL26468733 0.85 KDM4E (0.31) MAPTKDM4ETSHRHTTL3MBTL1
SCHEMBL13487056 0.84 CCR1 (0.36) CCR1CCR8MAPTCCR5LMNA
SCHEMBL13152951 0.83 CCR1 (0.39) CCR1CCR8MAPTCCR5LMNA
SCHEMBL26468608 0.83 CCR1 (0.35) CCR1CCR8MAPTCCR5LMNA
SCHEMBL10009973 0.82 PDK2 (0.37) CCR1CCR8MAPTCCR5LMNA
SCHEMBL13487352 0.82 CCR1 (0.32) CCR1CCR8MAPTCCR5LMNA
SCHEMBL13487274 0.82 CYP17A1 (0.33) CCR1CCR8MAPTCCR5LMNA
SCHEMBL13487108 0.82 TOP1 (0.32) CCR1CCR8MAPTCCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 US disclosed
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 US disclosed
WO-2010114266-A2 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD1, OCIAD2, ODC1 CCR1 4620/4885CCR8 3711/4885MAPT 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.